LRRK2 and congenital adrenal hyperplasia: In the GP2 cohort, the LRRK2 p.A419V variant was found to be rare (MAF < 1%) across all populations (Table 1), with the highest frequency observed in the EAS (MAF = 1.3% cases, 0.36% controls), followed by CAS (MAF = 0.98% cases, 0.6% controls), CAH (MAF = 1.1% cases, none in controls), EUR (MAF = 0.12% cases, 0.02% controls), AJ (MAF = 0.03% cases, none in controls).